speb/financial-data huggingface dataset:
Financial ratios for CBIO — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -21030000
Net income: -21790000
Capital expenditures: 140000
Operating cash flow: -16402000
Depreciation & amortization: 2000
Net tangible assets: 139254000
Owner earnings: -21928000
Return on net tangible assets (%): -15.746764904419264
Buffett classification: The Gruesome
Stock price: 16.14
Shares outstanding: 36959831
Book value: 139254000
P/B ratio: 4.283766874488346
Market cap (USD): 596531672.34
Debt to equity: 0.011805765004954975
Current ratio: 9.209781440343964
Quick ratio: 9.209781440343964
Interest coverage ratio: -19.599254426840634
Free cash flow (dilution-adjusted): -21882000
Buyback yield (%): 0
Retained earnings: -54805000
Capitalized R&D asset: 19201090
ROCI (R&D-adjusted, %): -10.331184351087897
Rule of 40 score: 0
Financial ratios for CBIO — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -25885000
Net income: -24607000
Capital expenditures: 586000
Operating cash flow: -17539000
Depreciation & amortization: 28000
Net tangible assets: 116641000
Owner earnings: -25165000
Return on net tangible assets (%): -21.574746444217727
Buffett classification: The Gruesome
Stock price: 11.89
Shares outstanding: 36959831
Book value: 116641000
P/B ratio: 3.7675636404866215
Market cap (USD): 439452390.59000003
Debt to equity: 0.01492614089385379
Current ratio: 6.627413317572892
Quick ratio: 6.627413317572892
Free cash flow (dilution-adjusted): -20111000
Buyback yield (%): 0
Retained earnings: -79412000
Capitalized R&D asset: 31948180
ROCI (R&D-adjusted, %): -13.267456981878889
Rule of 40 score: 0
Financial ratios for CBIO — annual report dated 2025-12-31
Total revenue: 10844000
Operating income: -152632000
Net income: -153942000
Capital expenditures: 919000
Operating cash flow: -71532000
Depreciation & amortization: 84000
Net tangible assets: 203012000
Owner earnings: -154777000
Return on net tangible assets (%): -76.24032076921561
Buffett classification: The Gruesome
Stock price: 11.86
Shares outstanding: 36959831
Book value: 203012000
P/B ratio: 2.1592004199751735
Market cap (USD): 438343595.65999997
Debt to equity: 0.008098043465410912
Current ratio: 6.56062874251497
Quick ratio: 6.56062874251497
Interest coverage ratio: -69.85446224256293
COGS to revenue (%): 0
R&D to revenue (%): 1273.3862043526374
SG&A to revenue (%): 234.13869420877904
Free cash flow (dilution-adjusted): -157751000
Buyback yield (%): 0.04037928277097256
Retained earnings: -171809000
Receivables turnover: 0.6024444444444444
Capitalized R&D asset: 138086000
ROCI (R&D-adjusted, %): -17.696005827127887
FCF margin (%): -1454.7307266691257
Rule of 40 score: -1454.7307266691257
Financial ratios for CBIO — quarterly report dated 2025-12-31
Total revenue: 10844000
Operating income: -91492000
Net income: -92397000
Capital expenditures: 193000
Operating cash flow: -26740000
Depreciation & amortization: 54000
Net tangible assets: 203012000
Owner earnings: -92536000
Return on net tangible assets (%): -45.58154197781412
Buffett classification: The Gruesome
Stock price: 11.86
Shares outstanding: 36959831
Book value: 203012000
P/B ratio: 2.1592004199751735
Market cap (USD): 438343595.65999997
Debt to equity: 0.008098043465410912
Current ratio: 6.56062874251497
Quick ratio: 6.56062874251497
COGS to revenue (%): 0
R&D to revenue (%): 876.309479896717
SG&A to revenue (%): 67.40132792327555
Free cash flow (dilution-adjusted): -103678000
Buyback yield (%): 0
Retained earnings: -171809000
Receivables turnover: 0.6024444444444444
Capitalized R&D asset: 112646220
ROCI (R&D-adjusted, %): -12.292215016750548
FCF margin (%): -956.0863150129103
Rule of 40 score: -956.0863150129103
Financial ratios for CEN.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.744360902255639
Shares outstanding: 994424083
Market cap (USD): 4717906739.646616
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEN.AX — annual report dated 2022-06-30
Total revenue: 1474534161.490683
Gross profit: 519875776.3975155
Operating income: 162732919.25465837
Net income: 113043478.26086956
Capital expenditures: 214906832.29813662
Depreciation & amortization: 162732919.25465837
Net tangible assets: 1506211180.1242235
Owner earnings: 60869565.21739134
Return on net tangible assets (%): 4.041237113402064
Capex to operating income (%): 132.06106870229007
Buffett classification: The Gruesome
Stock price: 3.8689655172413797
P/E ratio: 34.03462584336605
Shares outstanding: 994424083
Book value: 1763975155.279503
P/B ratio: 2.1810922195396554
Market cap (USD): 3847392486.64138
Debt to equity: 0.3869718309859155
Current ratio: 0.7288378766140603
Quick ratio: 0.6456241032998565
Effective tax rate (%): 28.063241106719367
Interest coverage ratio: 7.485714285714286
COGS to revenue (%): 64.74304970513901
Free cash flow (dilution-adjusted): 32919254.65838509
Buyback yield (%): 0
Retained earnings: 595031055.900621
Inventory turnover: 26.5
Receivables turnover: 10.742081447963802
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.8626090848064445
FCF margin (%): 2.232518955349621
Rule of 40 score: 2.232518955349621
Financial ratios for CEN.AX — annual report dated 2023-06-30
Total revenue: 1273333333.3333335
Gross profit: 481212121.21212125
Operating income: 160000000
Net income: 76969696.96969697
Capital expenditures: 318181818.1818182
Depreciation & amortization: 135757575.75757575
Net tangible assets: 1447272727.2727273
Owner earnings: -105454545.45454547
Return on net tangible assets (%): -7.286432160804021
Capex to operating income (%): 198.86363636363637
Buffett classification: The Gruesome
Stock price: 4.357615894039735
P/E ratio: 56.29901584779162
Shares outstanding: 994424083
Book value: 1699393939.3939393
P/B ratio: 2.5499197620076806
Market cap (USD): 4333318189.496688
Debt to equity: 0.5549215406562055
Current ratio: 0.7602564102564103
Quick ratio: 0.6987179487179488
Effective tax rate (%): 28.24858757062147
Interest coverage ratio: 6
COGS to revenue (%): 62.20847215611612
Free cash flow (dilution-adjusted): -88484848.48484848
Buyback yield (%): 0
Retained earnings: 492727272.72727275
Inventory turnover: 27.229166666666664
Receivables turnover: 8.681818181818182
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.250596658711218
FCF margin (%): -6.949071870537839
Revenue growth (%): -13.64504352709911
Rule of 40 score: -20.594115397636948
Financial ratios for CEN.AX — annual report dated 2024-06-30
Total revenue: 1732317073.1707318
Gross profit: 620121951.2195122
Operating income: 245731707.3170732
Net income: 143292682.92682928
Capital expenditures: 307926829.2682927
Depreciation & amortization: 152439024.39024392
Net tangible assets: 1330487804.878049
Owner earnings: -12195121.9512195
Return on net tangible assets (%): -0.916590284142987
Capex to operating income (%): 125.31017369727047
Buffett classification: The Gruesome
Stock price: 4.88
P/E ratio: 33.8662758343217
Shares outstanding: 994424083
Book value: 1596951219.512195
P/B ratio: 3.0387838186581138
Market cap (USD): 4852789525.04
Debt to equity: 0.7304314623902254
Current ratio: 0.7094668117519042
Quick ratio: 0.6692056583242654
Effective tax rate (%): 30.473372781065088
Interest coverage ratio: 8.574468085106384
COGS to revenue (%): 64.20274551214361
Free cash flow (dilution-adjusted): 45121951.219512194
Buyback yield (%): 0
Retained earnings: 471341463.41463417
Inventory turnover: 49.2972972972973
Receivables turnover: 10.640449438202246
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.619587823785215
FCF margin (%): 2.60471664906723
Revenue growth (%): 36.04584344272761
Rule of 40 score: 38.65056009179484
Financial ratios for CLBT — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 630645.1612903225
Buffett classification: The Gruesome
Stock price: 8.02
Shares outstanding: 249439817
Market cap (USD): 2000507332.34
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLBT — annual report dated 2022-12-31
Total revenue: 76889488.63636364
Gross profit: 62473011.36363637
Operating income: 296590.9090909091
Net income: 34319602.27272727
Capital expenditures: 1959375
Operating cash flow: 5845738.636363637
Depreciation & amortization: 2611931.8181818184
Net tangible assets: 10165340.909090908
Owner earnings: 34972159.09090909
Return on net tangible assets (%): 344.03331283885757
Capex to operating income (%): 660.6321839080459
Buffett classification: The Gruesome
Stock price: 4.36
P/E ratio: 31.689108558937132
Shares outstanding: 249439817
Book value: 20984375
P/B ratio: 51.82701901390916
Market cap (USD): 1087557602.1200001
Debt to equity: 0.2078927773641102
Current ratio: 1.4242721764199116
Quick ratio: 1.3752965920193283
Effective tax rate (%): -0.03726399470023187
Interest coverage ratio: 7.006711409395973
COGS to revenue (%): 18.749607428016155
R&D to revenue (%): 29.787438435475945
SG&A to revenue (%): 51.0772175236744
Free cash flow (dilution-adjusted): -629545.4545454546
Buyback yield (%): 0
Retained earnings: 56603125
Inventory turnover: 4.9868317610062896
Receivables turnover: 3.436358096011986
Capitalized R&D asset: 22903409.09090909
ROCI (R&D-adjusted, %): 19.84191364641578
FCF margin (%): -0.8187666034856698
Rule of 40 score: -0.8187666034856698
Financial ratios for CLBT — annual report dated 2023-12-31
Total revenue: 89809392.26519337
Gross profit: 75104696.13259669
Operating income: 9181491.712707182
Net income: -22403314.917127073
Capital expenditures: 1445027.6243093922
Operating cash flow: 28192817.67955801
Depreciation & amortization: 2765469.6132596685
Net tangible assets: -887016.5745856353
Owner earnings: -21082872.928176794
Capex to operating income (%): 15.738484219394048
Buffett classification: The Great
Stock price: 8.66
Shares outstanding: 249439817
Book value: 9450828.729281753
P/B ratio: 228.56713174022016
Market cap (USD): 2160148815.2200003
Debt to equity: 0.41298374839237756
Current ratio: 1.662892397881997
Quick ratio: 1.6237314044377205
Interest coverage ratio: 235.72340425531917
COGS to revenue (%): 16.373227522992217
R&D to revenue (%): 25.95613792254929
SG&A to revenue (%): 47.447325520593026
Free cash flow (dilution-adjusted): 20757458.56353591
Buyback yield (%): 0
Retained earnings: 32636187.845303867
Inventory turnover: 5.3552313883299805
Receivables turnover: 4.207508832778993
Capitalized R&D asset: 38656333.814665996
ROCI (R&D-adjusted, %): 14.763247373954
Rosenberg metric: 0.5515198509890886
FCF margin (%): 23.11279259327612
Revenue growth (%): 16.803211801722757
Rule of 40 score: 39.91600439499888
Financial ratios for CLBT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.84
Shares outstanding: 249439817
Market cap (USD): 4200566518.2799997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLBT — annual report dated 2024-12-31
Total revenue: 109918630.1369863
Gross profit: 92769863.01369864
Operating income: 15590684.93150685
Net income: -77536164.38356164
Capital expenditures: 2346849.315068493
Operating cash flow: 36211232.87671233
Depreciation & amortization: 2906027.3972602743
Net tangible assets: 81095890.4109589
Owner earnings: -76976986.30136986
Return on net tangible assets (%): -94.92094594594595
Capex to operating income (%): 15.052894246652373
Buffett classification: The Great
Stock price: 22.03
Shares outstanding: 249439817
Book value: 92060273.97260275
P/B ratio: 59.69088436718498
Market cap (USD): 5495159168.51
Debt to equity: 0.03264389024462829
Current ratio: 1.9207754939052866
Quick ratio: 1.8905252756326525
Interest coverage ratio: 1962.2758620689654
COGS to revenue (%): 15.601329003023407
R&D to revenue (%): 24.52997609688861
SG&A to revenue (%): 45.684852805188406
Free cash flow (dilution-adjusted): 24927945.20547945
Buyback yield (%): 0
Retained earnings: -45168219.17808219
Inventory turnover: 7.002237386732296
Receivables turnover: 4.871451467981252
Capitalized R&D asset: 50139542.01354727
ROCI (R&D-adjusted, %): 11.467108153968192
Rosenberg metric: 0.7578022907779616
FCF margin (%): 22.678544278083663
Revenue growth (%): 22.39101876161619
Rule of 40 score: 45.06956303969986
Financial ratios for CLBT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.03
Shares outstanding: 249439817
Market cap (USD): 5495159168.51
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLBT — quarterly report dated 2025-03-31
Total revenue: 29146070.460704606
Gross profit: 24406233.062330622
Operating income: 3324661.246612466
Net income: 4715447.154471545
Capital expenditures: 633875.3387533876
Operating cash flow: 5657994.5799458
Depreciation & amortization: 713008.1300813009
Net tangible assets: 87766395.66395664
Owner earnings: 4794579.945799458
Return on net tangible assets (%): 5.46288805587634
Capex to operating income (%): 19.06586240626019
Buffett classification: The Great
Stock price: 19.43
P/E ratio: 256.954191487125
Shares outstanding: 249439817
Book value: 98507859.07859078
P/B ratio: 49.20029416580164
Market cap (USD): 4846615644.309999
Debt to equity: 0.029169669925775944
Current ratio: 1.8189216047366554
Quick ratio: 1.7877573853883628
Effective tax rate (%): 9.975165562913906
COGS to revenue (%): 16.262354833610726
R&D to revenue (%): 25.362392955768996
SG&A to revenue (%): 46.96835860863421
Free cash flow (dilution-adjusted): 2645528.4552845526
Buyback yield (%): 0
Retained earnings: -39963143.63143632
Inventory turnover: 1.9500501728174824
Receivables turnover: 1.3254418180473737
Capitalized R&D asset: 7392140.921409214
ROCI (R&D-adjusted, %): 6.7767316241294315
FCF margin (%): 9.076792903699708
Rule of 40 score: 9.076792903699708
Financial ratios for CLBT — quarterly report dated 2025-06-30
Total revenue: 33414749.262536872
Gross profit: 28200294.985250738
Operating income: 4252802.3598820055
Net income: 5745132.743362832
Capital expenditures: 1064306.7846607668
Operating cash flow: 9611504.424778761
Depreciation & amortization: 764601.7699115044
Net tangible assets: 108984365.78171091
Owner earnings: 5445427.728613569
Return on net tangible assets (%): 4.996521922713605
Capex to operating income (%): 25.02601095928418
Buffett classification: The Good
Stock price: 16
P/E ratio: 381.5311494180407
Shares outstanding: 249439817
Book value: 120475811.20943953
P/B ratio: 33.127289469434125
Market cap (USD): 3991037072
Debt to equity: 0.05467749557433284
Current ratio: 1.9553858611667618
Quick ratio: 1.9246182682784407
Effective tax rate (%): 6.324852099466114
COGS to revenue (%): 15.605247360429395
R&D to revenue (%): 25.2577774638935
SG&A to revenue (%): 46.40965429570253
Free cash flow (dilution-adjusted): 5948377.581120944
Buyback yield (%): 0
Retained earnings: -37754572.27138643
Inventory turnover: 1.8535178777393313
Receivables turnover: 1.2163604540036725
Capitalized R&D asset: 13392557.42619373
ROCI (R&D-adjusted, %): 4.807794833457485
Rosenberg metric: 0.5132561680380989
FCF margin (%): 17.801652600727426
Revenue growth (%): 14.645812400636975
Rule of 40 score: 32.4474650013644
Financial ratios for CLBT — quarterly report dated 2025-09-30
Total revenue: 38075226.58610272
Gross profit: 31938066.465256795
Operating income: 5737160.120845921
Net income: 6099395.770392749
Capital expenditures: 1003625.3776435045
Operating cash flow: 10051963.746223565
Depreciation & amortization: 816616.3141993957
Net tangible assets: 123614501.51057401
Owner earnings: 5912386.706948641
Return on net tangible assets (%): 4.782923228827561
Capex to operating income (%): 17.49341758820432
Buffett classification: The Great
Stock price: 18.53
P/E ratio: 279.1139251417049
Shares outstanding: 249439817
Book value: 135252265.86102718
P/B ratio: 34.174065621638206
Market cap (USD): 4622119809.01
Debt to equity: 0.04788858237376727
Current ratio: 2.1090758779112515
Quick ratio: 2.0817879760315794
Effective tax rate (%): 16.876646903820816
COGS to revenue (%): 16.11851240587484
R&D to revenue (%): 22.315498813765085
SG&A to revenue (%): 46.49802823159749
Free cash flow (dilution-adjusted): 4423564.9546827795
Buyback yield (%): 0
Retained earnings: -32567975.83081571
Inventory turnover: 2.348982423681776
Receivables turnover: 1.2095377941571654
Capitalized R&D asset: 16590764.657154365
ROCI (R&D-adjusted, %): 3.541985391042566
Rosenberg metric: 0.44287320671142344
FCF margin (%): 11.617960945496671
Revenue growth (%): 13.947365838207752
Rule of 40 score: 25.56532678370442
Financial ratios for CLBT — quarterly report dated 2025-12-31
Total revenue: 40509748.42767295
Gross profit: 34317610.06289308
Operating income: 6542452.830188679
Net income: 6685849.0566037735
Capital expenditures: 1244025.1572327043
Operating cash flow: 27299056.603773583
Depreciation & amortization: 1239308.176100629
Net tangible assets: 89084905.66037735
Owner earnings: 6681132.075471698
Return on net tangible assets (%): 7.499735253627025
Capex to operating income (%): 19.01465993751502
Buffett classification: The Great
Stock price: 18.03
P/E ratio: 193.47129877073942
Shares outstanding: 249439817
Book value: 152301257.86163524
P/B ratio: 29.5296307046647
Market cap (USD): 4497399900.51
Debt to equity: 0.046808088900268
Current ratio: 1.5577954698544867
Quick ratio: 1.5372277543777069
Effective tax rate (%): 19.070457919378782
COGS to revenue (%): 15.285551268814867
R&D to revenue (%): 23.183331910169926
SG&A to revenue (%): 45.38079971433229
Free cash flow (dilution-adjusted): 22282389.93710692
Buyback yield (%): 0
Retained earnings: -27213207.54716981
Inventory turnover: 2.5898987241878206
Receivables turnover: 1.227193918378234
Capitalized R&D asset: 17869424.4407799
ROCI (R&D-adjusted, %): 3.6360369704218054
Rosenberg metric: 0.280055799608025
FCF margin (%): 55.005006947625
Revenue growth (%): 6.393978604604877
Rule of 40 score: 61.398985552229874
Financial ratios for CLBT — annual report dated 2025-12-31
Total revenue: 149583333.3333333
Gross profit: 125944339.6226415
Operating income: 20905660.37735849
Net income: 24630817.610062893
Capital expenditures: 4158805.0314465407
Operating cash flow: 54573584.905660376
Depreciation & amortization: 3731761.006289308
Net tangible assets: 89084905.66037735
Owner earnings: 24203773.58490566
Return on net tangible assets (%): 27.169331780154614
Capex to operating income (%): 19.89320096269555
Buffett classification: The Great
Stock price: 18.03
P/E ratio: 182.5923918446212
Shares outstanding: 249439817
Book value: 152301257.86163524
P/B ratio: 29.5296307046647
Market cap (USD): 4497399900.51
Debt to equity: 0.046808088900268
Current ratio: 1.5577954698544867
Quick ratio: 1.5372277543777069
Effective tax rate (%): 13.621826683429278
Interest coverage ratio: 127.11281070745697
COGS to revenue (%): 15.803226993220163
R&D to revenue (%): 23.9400851421664
SG&A to revenue (%): 46.280758921532566
Free cash flow (dilution-adjusted): 36297798.74213836
Buyback yield (%): 0
Retained earnings: -27213207.54716981
Inventory turnover: 9.887149809285809
Receivables turnover: 4.531446480966353
Capitalized R&D asset: 61568242.94541253
ROCI (R&D-adjusted, %): 11.648312157474926
Rosenberg metric: 1.230369756872849
FCF margin (%): 24.26593787775267
Revenue growth (%): 36.08551448186245
Rule of 40 score: 60.35145235961512
Financial ratios for CNTN — annual report dated 2022-12-31
Total revenue: 0
Operating income: -6881938
Net income: -8473182
Capital expenditures: 0
Operating cash flow: -6557950
Net tangible assets: 5543655
Owner earnings: -8473182
Return on net tangible assets (%): -152.84468459887927
Buffett classification: The Gruesome
Stock price: 146.25
Shares outstanding: 77122584
Book value: 5543655
P/B ratio: 2034.6103626578492
Market cap (USD): 11279177910
Debt to equity: 0
Current ratio: 5.841734259235808
Quick ratio: 5.841734259235808
Interest coverage ratio: -4.324879151154694
Free cash flow (dilution-adjusted): -7358646
Buyback yield (%): 0.0006203023000281764
Retained earnings: -15384432
Capitalized R&D asset: 2278424
ROCI (R&D-adjusted, %): -68.56219000941651
Rule of 40 score: 0
Financial ratios for CNTN — annual report dated 2023-12-31
Total revenue: 0
Operating income: -9455220
Net income: -9319094
Capital expenditures: 0
Operating cash flow: -7300106
Net tangible assets: 9131347
Owner earnings: -9319094
Return on net tangible assets (%): -102.05607124556761
Buffett classification: The Gruesome
Stock price: 7.64
Shares outstanding: 77122584
Book value: 9131347
P/B ratio: 64.52679344679377
Market cap (USD): 589216541.76
Debt to equity: 0
Current ratio: 6.03091767371185
Quick ratio: 6.03091767371185
Interest coverage ratio: -572.8700393820054
Free cash flow (dilution-adjusted): -8131968
Buyback yield (%): 0
Retained earnings: -24703526
Capitalized R&D asset: 5086179.08
ROCI (R&D-adjusted, %): -55.15449468875999
Rule of 40 score: 0
Financial ratios for CNTN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.48
Shares outstanding: 77122584
Market cap (USD): 191264008.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNTN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.03
Shares outstanding: 77122584
Market cap (USD): 156558845.51999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNTN — annual report dated 2024-12-31
Total revenue: 0
Operating income: -12433792
Net income: -12197568
Capital expenditures: 0
Operating cash flow: -10901991
Net tangible assets: 1307642
Owner earnings: -12197568
Return on net tangible assets (%): -932.7910850217414
Buffett classification: The Gruesome
Stock price: 2.03
Shares outstanding: 77122584
Book value: 1307642
P/B ratio: 119.72607603610162
Market cap (USD): 156558845.51999998
Debt to equity: 0
Current ratio: 1.541695008496335
Quick ratio: 1.541695008496335
Interest coverage ratio: -908.6372405729319
Free cash flow (dilution-adjusted): -11612304
Buyback yield (%): 0
Retained earnings: -36901094
Capitalized R&D asset: 9528932.37
ROCI (R&D-adjusted, %): -93.37280695160003
Rule of 40 score: 0
Financial ratios for CNTN — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -2546669
Net income: -2541704
Capital expenditures: 0
Operating cash flow: -2689001
Net tangible assets: -814671
Owner earnings: -2541704
Buffett classification: The Gruesome
Stock price: 1.36
Shares outstanding: 77122584
Book value: -814671
Market cap (USD): 104886714.24000001
Debt to equity: -0.3332069019272811
Current ratio: 0.6709682891317122
Quick ratio: 0.6709682891317122
Interest coverage ratio: -300.6338094675953
Free cash flow (dilution-adjusted): -2908180
Buyback yield (%): 0
Retained earnings: -39442798
Capitalized R&D asset: 594070
Rule of 40 score: 0
Financial ratios for CNTN — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -1851160
Net income: -1855153
Capital expenditures: 0
Operating cash flow: -1142530
Net tangible assets: 367359
Owner earnings: -1855153
Return on net tangible assets (%): -504.9972914778187
Buffett classification: The Gruesome
Stock price: 1.94
Shares outstanding: 77122584
Book value: 367359
P/B ratio: 407.2795629343503
Market cap (USD): 149617812.96
Debt to equity: 0.6797601256536522
Current ratio: 1.1698528810014024
Quick ratio: 1.1698528810014024
Interest coverage ratio: -300.4642103554618
Free cash flow (dilution-adjusted): -1701913
Buyback yield (%): 0
Retained earnings: -41297951
Capitalized R&D asset: 944230.9
ROCI (R&D-adjusted, %): -128.47364357817435
Rule of 40 score: 0
Financial ratios for CNTN — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -2093578
Net income: -2101838
Capital expenditures: 0
Operating cash flow: -1855169
Net tangible assets: 6154827
Owner earnings: -2101838
Return on net tangible assets (%): -34.149424508601136
Buffett classification: The Gruesome
Stock price: 2.84
Shares outstanding: 77122584
Book value: 6154827
P/B ratio: 35.586400488592126
Market cap (USD): 219028138.56
Debt to equity: 0.026177340159195376
Current ratio: 4.98486485716561
Quick ratio: 4.98486485716561
Interest coverage ratio: -216.99606135986733
Free cash flow (dilution-adjusted): -2382183
Buyback yield (%): 0
Retained earnings: -43399789
Capitalized R&D asset: 839802.7799999999
ROCI (R&D-adjusted, %): -32.71749049359026
Rule of 40 score: 0
Financial ratios for CNTN — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -13614659
Net income: -29417555
Capital expenditures: 0
Operating cash flow: -10441616
Net tangible assets: -103834489
Owner earnings: -29417555
Buffett classification: The Gruesome
Stock price: 3.03
Shares outstanding: 77122584
Book value: 397925880
P/B ratio: 0.5872486341426197
Market cap (USD): 233681429.51999998
Debt to equity: 0
Current ratio: 5.290365279074381
Quick ratio: 5.290365279074381
Interest coverage ratio: -3349.239606396064
Free cash flow (dilution-adjusted): -89586463
Buyback yield (%): 0
Retained earnings: -72817344
Capitalized R&D asset: 2022262.33
ROCI (R&D-adjusted, %): -2.4687853804787627
Rule of 40 score: 0
Financial ratios for CNTN — annual report dated 2025-12-31
Total revenue: 0
Operating income: -20106066
Net income: -35916250
Capital expenditures: 77572567
Operating cash flow: -16128316
Net tangible assets: -103834489
Owner earnings: -113488817
Buffett classification: The Gruesome
Stock price: 3.03
Shares outstanding: 77122584
Book value: 397925880
P/B ratio: 0.5872486341426197
Market cap (USD): 233681429.51999998
Debt to equity: 0
Current ratio: 5.290365279074381
Quick ratio: 5.290365279074381
Interest coverage ratio: -709.3337802081496
Free cash flow (dilution-adjusted): -96578739
Buyback yield (%): 0
Retained earnings: -72817344
Capitalized R&D asset: 8531348.540000001
ROCI (R&D-adjusted, %): -4.075963082198427
Rule of 40 score: 0
Financial ratios for DTSS — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 37.5
Shares outstanding: 6447153
Market cap (USD): 241768237.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DTSS — annual report dated 2022-06-30
Total revenue: 2549389.7014925373
Gross profit: 142637.76119402985
Operating income: -1080187.1641791044
Net income: -973389.2537313433
Capital expenditures: 7662.686567164179
Operating cash flow: -767121.1940298508
Depreciation & amortization: 86242.0895522388
Net tangible assets: 106285.67164179104
Owner earnings: -894809.8507462686
Return on net tangible assets (%): -841.8913263887525
Buffett classification: The Gruesome
Stock price: 24.45
Shares outstanding: 6447153
Book value: 238751.0447761194
P/B ratio: 660.239585539049
Market cap (USD): 157632890.85
Debt to equity: 0.35718777818898345
Current ratio: 0.5915540755209866
Quick ratio: 0.49207394420060485
COGS to revenue (%): 94.40502324495455
R&D to revenue (%): 7.3751277083523235
SG&A to revenue (%): 40.59027062432443
Free cash flow (dilution-adjusted): -1027487.0149253731
Buyback yield (%): 0
Retained earnings: -2773666.567164179
Inventory turnover: 76.29528797793265
Receivables turnover: 65.84522955938476
Capitalized R&D asset: 188020.74626865672
ROCI (R&D-adjusted, %): -221.29989162323352
FCF margin (%): -40.303254317056044
Rule of 40 score: -40.303254317056044
Financial ratios for DTSS — annual report dated 2023-06-30
Total revenue: 502164.1379310345
Gross profit: 18687.03448275862
Operating income: -1128857.103448276
Net income: -1307543.7241379311
Capital expenditures: 535.3103448275862
Operating cash flow: -432562.8965517241
Depreciation & amortization: 96748.96551724138
Net tangible assets: -648970.4827586206
Owner earnings: -1211330.0689655175
Buffett classification: The Gruesome
Stock price: 13.76
Shares outstanding: 6447153
Book value: -493806.4827586207
Market cap (USD): 88712825.28
Debt to equity: -0.599848551589524
Current ratio: 0.26281408110545545
Quick ratio: 0.2136188685590254
COGS to revenue (%): 96.27869991677403
R&D to revenue (%): 15.646347258349378
SG&A to revenue (%): 212.87338389151506
Free cash flow (dilution-adjusted): -1048177.5172413792
Buyback yield (%): 0
Retained earnings: -3870794.206896552
Inventory turnover: 14.521538652746708
Receivables turnover: 14.236738684133346
Capitalized R&D asset: 204544.24482758623
Rosenberg metric: -0.6592396273875122
FCF margin (%): -208.73205353930163
Revenue growth (%): -80.30257446960569
Rule of 40 score: -289.0346280089073
Financial ratios for DTSS — annual report dated 2024-06-30
Total revenue: 3297918.431911967
Gross profit: 65213.892709766165
Operating income: -1667866.1623108666
Net income: -1564933.1499312243
Capital expenditures: 944.7042640990372
Operating cash flow: -880176.4786795048
Depreciation & amortization: 68016.50618982119
Net tangible assets: -107667.95048143054
Owner earnings: -1497861.348005502
Buffett classification: The Gruesome
Stock price: 4.5
Shares outstanding: 6447153
Book value: -42404.12654745532
Market cap (USD): 29012188.5
Debt to equity: -3.969884325187004
Current ratio: 0.7355292332017216
Quick ratio: 0.6928670754464883
COGS to revenue (%): 98.02257411588077
R&D to revenue (%): 1.498765404396012
SG&A to revenue (%): 51.05195987281711
Free cash flow (dilution-adjusted): -1831654.8830811554
Buyback yield (%): 0
Retained earnings: -5425078.679504815
Inventory turnover: 153.02319918220118
Receivables turnover: 33.36719848137767
Capitalized R&D asset: 164117.0378258355
ROCI (R&D-adjusted, %): -1416.2653747159836
Rosenberg metric: 0.592168181635266
FCF margin (%): -55.53972667599465
Revenue growth (%): 556.7411296035027
Rule of 40 score: 501.20140292750807
Financial ratios for DTSS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.5
Shares outstanding: 6447153
Market cap (USD): 16117882.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DTSS — quarterly report dated 2024-12-31
Total revenue: 2802247.1232876712
Gross profit: 57185.20547945206
Operating income: -169637.2602739726
Net income: -154481.64383561644
Capital expenditures: 616.8493150684932
Operating cash flow: -117111.91780821918
Depreciation & amortization: 42480.27397260274
Net tangible assets: -115818.90410958904
Owner earnings: -112618.2191780822
Buffett classification: The Gruesome
Stock price: 2.29
Shares outstanding: 6447153
Book value: 441973.698630137
P/B ratio: 33.40465827663457
Market cap (USD): 14763980.370000001
Debt to equity: 0.4078802184968547
Current ratio: 0.6230101491814451
Quick ratio: 0.49805159932117465
COGS to revenue (%): 97.95930897727675
R&D to revenue (%): 0.3637100636064873
SG&A to revenue (%): 7.730596247512516
Free cash flow (dilution-adjusted): -677592.3287671233
Buyback yield (%): 0
Retained earnings: -5827203.97260274
Inventory turnover: 62.6350349449258
Receivables turnover: 96.95897241444686
Capitalized R&D asset: 10192.054794520549
ROCI (R&D-adjusted, %): -34.78289535925968
FCF margin (%): -24.180320255700856
Rule of 40 score: -24.180320255700856
Financial ratios for DTSS — quarterly report dated 2025-03-31
Total revenue: 1426167.6308539945
Gross profit: 41017.906336088156
Operating income: -243729.88980716254
Net income: -245592.01101928376
Capital expenditures: 1.6528925619834711
Operating cash flow: -27256.749311294767
Depreciation & amortization: 52199.586776859505
Net tangible assets: -132661.57024793388
Owner earnings: -193394.07713498623
Buffett classification: The Gruesome
Stock price: 2.17
Shares outstanding: 6447153
Book value: 390150.6887052342
P/B ratio: 35.85876538223911
Market cap (USD): 13990322.01
Debt to equity: 0.8074859117089037
Current ratio: 0.6353339357384837
Quick ratio: 0.5343932896749247
COGS to revenue (%): 97.12390707454729
R&D to revenue (%): 3.3565073594426567
SG&A to revenue (%): 16.609434229958207
Free cash flow (dilution-adjusted): -191659.0909090909
Buyback yield (%): 0
Retained earnings: -6104901.790633609
Inventory turnover: 31.809786958103338
Receivables turnover: 211.0214201279909
Capitalized R&D asset: 54698.09819993208
ROCI (R&D-adjusted, %): -45.691302978918245
Rosenberg metric: -1.5862649357081327
FCF margin (%): -13.438749187872448
Revenue growth (%): -49.106286201454765
Rule of 40 score: -62.54503538932721
Financial ratios for DTSS — annual report dated 2025-06-30
Total revenue: 9988398.884239888
Gross profit: 340857.4616457462
Operating income: -718928.1729428173
Net income: -709301.8131101814
Capital expenditures: 1133.7517433751743
Operating cash flow: -331196.65271966526
Depreciation & amortization: 158893.1659693166
Net tangible assets: -75840.44630404463
Owner earnings: -551542.39888424
Buffett classification: The Gruesome
Stock price: 1.94
Shares outstanding: 6447153
Book value: 410347.9776847977
P/B ratio: 30.480171708333405
Market cap (USD): 12507476.82
Debt to equity: 0.9073932897037758
Current ratio: 0.8056439451375008
Quick ratio: 0.748683437866152
COGS to revenue (%): 96.58746646388377
R&D to revenue (%): 1.2776272389642545
SG&A to revenue (%): 9.332538082534244
Free cash flow (dilution-adjusted): -1164953.8354253836
Buyback yield (%): 0
Retained earnings: -6210044.072524407
Inventory turnover: 334.79924495426167
Receivables turnover: 52.116040111193584
Capitalized R&D asset: 186659.51922476027
ROCI (R&D-adjusted, %): -109.07703936260074
Rosenberg metric: 5.576661637561362
FCF margin (%): -11.663068815398397
Revenue growth (%): 202.86979773629866
Rule of 40 score: 191.20672892090028
Financial ratios for DTSS — quarterly report dated 2025-06-30
Total revenue: 2751094.1422594143
Gross profit: 213629.7071129707
Operating income: -16225.10460251046
Net income: -28511.715481171548
Capital expenditures: 123.57043235704323
Operating cash flow: -82179.07949790795
Depreciation & amortization: 50844.351464435145
Net tangible assets: -75840.44630404463
Owner earnings: 22209.065550906555
Buffett classification: The Gruesome
Stock price: 1.94
Shares outstanding: 6447153
Book value: 410347.9776847977
P/B ratio: 30.480171708333405
Market cap (USD): 12507476.82
Debt to equity: 0.9073932897037758
Current ratio: 0.8056439451375008
Quick ratio: 0.748683437866152
COGS to revenue (%): 92.23473657875185
R&D to revenue (%): 1.9770655468890403
SG&A to revenue (%): 6.377967026685718
Free cash flow (dilution-adjusted): -119898.88423988843
Buyback yield (%): 0
Retained earnings: -6210044.072524407
Inventory turnover: 88.0577900392043
Receivables turnover: 14.354265816705237
Capitalized R&D asset: 89826.82492797944
ROCI (R&D-adjusted, %): 0.13024628250336176
Rosenberg metric: 3.6058885905187648
FCF margin (%): -4.358225420138406
Revenue growth (%): 92.9011767440023
Rule of 40 score: 88.54295132386389
Financial ratios for DTSS — quarterly report dated 2025-09-30
Total revenue: 1940105.47752809
Gross profit: 164198.31460674157
Operating income: -40536.93820224719
Net income: -28233.988764044945
Capital expenditures: 0
Operating cash flow: 123497.05056179775
Depreciation & amortization: 65274.01685393258
Net tangible assets: -223317.27528089887
Owner earnings: 37040.02808988764
Buffett classification: The Gruesome
Stock price: 2.02
Shares outstanding: 6447153
Book value: 423237.64044943836
P/B ratio: 30.770536018891278
Market cap (USD): 13023249.06
Debt to equity: 1.1400662761510716
Current ratio: 0.6657175266120501
Quick ratio: 0.6165988552023774
COGS to revenue (%): 91.53662950243569
R&D to revenue (%): 3.713194384268028
SG&A to revenue (%): 6.839595408885087
Free cash flow (dilution-adjusted): -129609.12921348313
Buyback yield (%): 0
Retained earnings: -6281887.921348315
Inventory turnover: 63.05394097758984
Receivables turnover: 11.787131010872773
Capitalized R&D asset: 124278.72281225113
ROCI (R&D-adjusted, %): -4.214268236128982
Rosenberg metric: -0.9088167542422694
FCF margin (%): -6.680519730227223
Revenue growth (%): -29.47876818440233
Rule of 40 score: -36.15928791462955
Financial ratios for DYNPRO.NS — annual report dated 2022-03-31
Total revenue: 31998536.19939338
Gross profit: 7443795.331662931
Operating income: 3832440.9864169853
Net income: 1885994.988790716
Capital expenditures: 7149742.8458393775
Operating cash flow: 5233535.540023738
Depreciation & amortization: 1486324.673612027
Net tangible assets: 22442964.525913227
Owner earnings: -3777423.1834366345
Return on net tangible assets (%): -16.831213091635572
Capex to operating income (%): 186.55845898683475
Buffett classification: The Gruesome
Stock price: 7.625214295133852
P/E ratio: 50.248868518267315
Shares outstanding: 12428387
Book value: 22490465.514967687
P/B ratio: 4.2137462274751805
Market cap (USD): 94769114.21785574
Debt to equity: 1.018674228298422
Current ratio: 0.9243482601824111
Quick ratio: 0.5324324466775444
Effective tax rate (%): 38.56453698413585
Interest coverage ratio: 4.5716308263461745
COGS to revenue (%): 76.73707545470768
SG&A to revenue (%): 2.816296571656771
Free cash flow (dilution-adjusted): -1931201.3714888566
Buyback yield (%): 0
Retained earnings: 18958169.589872085
Inventory turnover: 3.5772819753200267
Receivables turnover: 5.16024201437625
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.313547252828371
FCF margin (%): -6.035280362373163
Rule of 40 score: -6.035280362373163
Financial ratios for DYNPRO.NS — annual report dated 2023-03-31
Total revenue: 35146297.19853837
Gross profit: 6665992.691839221
Operating income: 1145322.7771010962
Net income: -357685.74908647995
Capital expenditures: 113069.42752740561
Operating cash flow: 3016857.4908647994
Depreciation & amortization: 2040012.1802679661
Net tangible assets: 22241741.778319124
Owner earnings: 1569257.0036540807
Capex to operating income (%): 9.872276164243708
Buffett classification: The Great
Stock price: 2.8453105968331305
Shares outstanding: 12428387
Book value: 22285992.691839226
P/B ratio: 1.5867644632941276
Market cap (USD): 35362621.23264312
Debt to equity: 0.808698242315596
Current ratio: 0.8757338795137327
Quick ratio: 0.43802082178378166
Interest coverage ratio: 0.9029981177735951
COGS to revenue (%): 81.03358469262463
SG&A to revenue (%): 2.937261372422424
Free cash flow (dilution-adjusted): 2903666.2606577347
Buyback yield (%): 0
Retained earnings: 17144360.535931792
Inventory turnover: 3.5896383699937364
Receivables turnover: 5.688560625177428
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.5696307864948444
FCF margin (%): 8.2616562542995
Revenue growth (%): 9.83720311307448
Rule of 40 score: 18.09885936737398
Financial ratios for DYNPRO.NS — annual report dated 2024-03-31
Total revenue: 33543086.70104329
Gross profit: 16411847.943398489
Operating income: 1807746.732222089
Net income: 433972.8984290682
Capital expenditures: 331838.349922053
Operating cash flow: 3628696.486389255
Depreciation & amortization: 2000719.5107327017
Net tangible assets: 24264636.04748771
Owner earnings: 2102854.0592397167
Return on net tangible assets (%): 8.66633258015605
Capex to operating income (%): 18.356462440629393
Buffett classification: The Great
Stock price: 3.125
P/E ratio: 89.49570241734368
Shares outstanding: 12428387
Book value: 24308346.32449934
P/B ratio: 1.5977520172096664
Market cap (USD): 38838709.375
Debt to equity: 0.56502207863259
Current ratio: 0.8718569951635495
Quick ratio: 0.4405710182490504
Effective tax rate (%): -16.472481493401997
Interest coverage ratio: 1.1692417473318442
COGS to revenue (%): 51.07233842349985
SG&A to revenue (%): 2.859867050770818
Free cash flow (dilution-adjusted): 3292684.974217532
Buyback yield (%): 0
Retained earnings: 17339477.155534238
Inventory turnover: 2.1701517432472053
Receivables turnover: 4.987995249457004
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.096949866835996
FCF margin (%): 9.8162849578036
Revenue growth (%): -4.561534572016747
Rule of 40 score: 5.254750385786853
Financial ratios for DYNPRO.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 24965611.562350694
Buffett classification: The Gruesome
Stock price: 4.563425704730053
Shares outstanding: 12428387
Book value: 25009089.823220257
P/B ratio: 2.2678162662070793
Market cap (USD): 56716020.704132825
Debt to equity: 0.5003508041271186
Current ratio: 0.880470722624519
Quick ratio: 0.4463564667136452
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DYNPRO.NS — quarterly report dated 2024-12-31
Total revenue: 10928977.736332905
Gross profit: 4919827.485720946
Operating income: 1020293.7405291991
Net income: 512064.34316353884
Capital expenditures: 0
Depreciation & amortization: 483681.08171115513
Owner earnings: 995745.424874694
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.74064576290943
P/E ratio: 28.765223041771
Shares outstanding: 12428387
Market cap (USD): 58918580.17134864
Effective tax rate (%): 25.18860373631239
Interest coverage ratio: 2.986590691961239
COGS to revenue (%): 54.98364435893033
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DYNPRO.NS — quarterly report dated 2025-03-31
Total revenue: 10853670.797287818
Gross profit: 5311959.317278466
Operating income: 980979.6586392331
Net income: 460451.25087678275
Capital expenditures: 0
Depreciation & amortization: 475333.177460837
Net tangible assets: 26185153.14472761
Owner earnings: 935784.4283376198
Return on net tangible assets (%): 3.5737214258990893
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.0575329676741743
P/E ratio: 20.63204460578283
Shares outstanding: 12428387
Book value: 26227788.169277534
P/B ratio: 1.4488527489338752
Market cap (USD): 38000202.987513125
Debt to equity: 0.4273426861746581
Current ratio: 0.9472743441158795
Quick ratio: 0.4575181500931851
Effective tax rate (%): 30.689096924051523
Interest coverage ratio: 2.823642237028064
COGS to revenue (%): 51.058407643929534
Buyback yield (%): 0
Retained earnings: 18667652.56020575
Inventory turnover: 0.5765062145793302
Receivables turnover: 1.4256409390201956
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3809643724125418
Revenue growth (%): -0.6890574842579458
Rule of 40 score: -0.6890574842579458
Financial ratios for DYNPRO.NS — annual report dated 2025-03-31
Total revenue: 42190483.984101005
Gross profit: 20014332.476034604
Operating income: 3675906.008884732
Net income: 1755611.4098667288
Capital expenditures: 804454.056581716
Operating cash flow: 3559632.920271218
Depreciation & amortization: 1920762.2165068972
Net tangible assets: 26185153.14472761
Owner earnings: 2871919.5697919102
Return on net tangible assets (%): 10.967740207279148
Capex to operating income (%): 21.884511046727958
Buffett classification: The Great
Stock price: 3.0575329676741743
P/E ratio: 21.644996594319117
Shares outstanding: 12428387
Book value: 26227788.169277534
P/B ratio: 1.4488527489338752
Market cap (USD): 38000202.987513125
Debt to equity: 0.4273426861746581
Current ratio: 0.9472743441158795
Quick ratio: 0.45751755447112635
Effective tax rate (%): 26.718522024701237
Interest coverage ratio: 2.7597201987045588
COGS to revenue (%): 52.56197467756763
SG&A to revenue (%): 2.387465246355335
Free cash flow (dilution-adjusted): 2751239.1863455693
Buyback yield (%): 0
Retained earnings: 18667652.56020575
Inventory turnover: 2.306990116276949
Receivables turnover: 5.5417639182349765
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.66907742981758
FCF margin (%): 6.52099460954831
Revenue growth (%): 25.77996879097223
Rule of 40 score: 32.30096340052054
Financial ratios for DYNPRO.NS — quarterly report dated 2025-06-30
Total revenue: 10873648.490521882
Gross profit: 5110238.708167564
Operating income: 1012274.7484203137
Net income: 563245.9630236368
Capital expenditures: 0
Depreciation & amortization: 482915.9840861222
Owner earnings: 1046161.9471097591
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.5174350573367663
P/E ratio: 28.46538509762158
Shares outstanding: 12428387
Market cap (USD): 43716044.139948525
Effective tax rate (%): 25.196985002719718
Interest coverage ratio: 3.836659570693632
COGS to revenue (%): 53.00345865859145
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 0.1840639319837841
Rule of 40 score: 0.1840639319837841
Financial ratios for DYNPRO.NS — quarterly report dated 2025-09-30
Total revenue: 9909131.90529876
Gross profit: 5122130.777903044
Operating income: 915817.3618940248
Net income: 500992.1082299887
Capital expenditures: 0
Depreciation & amortization: 469571.5896279594
Net tangible assets: 26263483.65276212
Owner earnings: 970563.6978579481
Return on net tangible assets (%): 3.695487280705332
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.967869222096956
P/E ratio: 24.212164238571688
Shares outstanding: 12428387
Book value: 26304757.60992108
P/B ratio: 1.8747260472383376
Market cap (USD): 49314214.25760992
Debt to equity: 0.3391154415848917
Current ratio: 1.0229240315335881
Quick ratio: 0.49808334870754145
Effective tax rate (%): 23.523439113375094
Interest coverage ratio: 3.465423830041381
COGS to revenue (%): 48.308985823833254
Buyback yield (%): 0
Inventory turnover: 0.5025476116362827
Receivables turnover: 1.2874073010790648
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2063168780318376
Revenue growth (%): -8.870220387056392
Rule of 40 score: -8.870220387056392
Financial ratios for DYNPRO.NS — quarterly report dated 2025-12-31
Total revenue: 9924685.3068954
Gross profit: 4542285.841595188
Operating income: 946752.8127436783
Net income: 513166.98228806956
Capital expenditures: 0
Depreciation & amortization: 464152.83502283617
Owner earnings: 977319.8173109058
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.931937172774869
P/E ratio: 17.881167462065108
Shares outstanding: 12428387
Market cap (USD): 36439249.84293193
Effective tax rate (%): 25.17582471129014
Interest coverage ratio: 3.4763579842931933
COGS to revenue (%): 54.23244464548078
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 0.15696028416295837
Rule of 40 score: 0.15696028416295837
Financial ratios for EOS.AX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.6956521739130435
Shares outstanding: 221702162
Market cap (USD): 375929752.95652175
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EOS.AX — annual report dated 2022-12-31
Total revenue: 93183783.78378378
Gross profit: 31429054.054054055
Operating income: -37732432.432432435
Net income: -77391891.8918919
Capital expenditures: 13008783.783783784
Depreciation & amortization: 7472297.297297297
Net tangible assets: 142888513.5135135
Owner earnings: -82928378.37837838
Return on net tangible assets (%): -58.03712022697719
Buffett classification: The Gruesome
Stock price: 0.3310810810810811
Shares outstanding: 221702162
Book value: 157494594.5945946
P/B ratio: 0.46605657585845933
Market cap (USD): 73401391.47297297
Debt to equity: 0.41693408611192145
Current ratio: 2.497075186319697
Quick ratio: 1.782895804109053
Interest coverage ratio: -4.317278701198299
COGS to revenue (%): 66.2719705319334
SG&A to revenue (%): 63.92337142525669
Free cash flow (dilution-adjusted): -47854729.72972973
Buyback yield (%): 0
Retained earnings: -140877702.7027027
Inventory turnover: 1.2212156438315895
Receivables turnover: 18.58902817091252
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.864077669902915
FCF margin (%): -51.35521201925866
Rule of 40 score: -51.35521201925866
Financial ratios for EOS.AX — annual report dated 2023-12-31
Total revenue: 150173287.67123288
Gross profit: 65465068.49315069
Operating income: -5492465.7534246575
Net income: -22791095.89041096
Capital expenditures: 2008904.1095890412
Depreciation & amortization: 8481506.84931507
Net tangible assets: 118117123.28767124
Owner earnings: -16318493.15068493
Return on net tangible assets (%): -13.815518611083727
Buffett classification: The Gruesome
Stock price: 0.7123287671232877
Shares outstanding: 221702162
Book value: 136352054.79452056
P/B ratio: 1.1582137721651247
Market cap (USD): 157924827.7260274
Debt to equity: 0.4457689100535479
Current ratio: 1.8998225031386642
Quick ratio: 1.2643231308714664
Interest coverage ratio: -0.2345697068975604
COGS to revenue (%): 56.40698188850324
SG&A to revenue (%): 40.72236183769435
Free cash flow (dilution-adjusted): 75473287.67123288
Buyback yield (%): 0
Retained earnings: -165598630.13698632
Inventory turnover: 1.6850007493494286
Receivables turnover: 25.89806283959367
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.887253454694712
FCF margin (%): 50.257465120203605
Revenue growth (%): 61.15817749972785
Rule of 40 score: 111.41564261993145